Skip to main content

Krogulski Kenneth's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Nov 5, 2021

Accession no.
0001209191-21-063219
Filed
Nov 5, 2021
Trade date
Oct 1-29, 2021
Filing delay
35 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $4.86K. It was filed 35 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krogulski KennethCIK 0001695580Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 1, 2021Common StockPPurchaseAcquired+85$2.69+$228.65177,440Direct
Oct 4, 2021Common StockPPurchaseAcquired+85$2.87+$243.95177,525Direct
Oct 5, 2021Common StockPPurchaseAcquired+85$2.82+$239.7177,610Direct
Oct 6, 2021Common StockPPurchaseAcquired+85$2.76+$234.6177,695Direct
Oct 7, 2021Common StockPPurchaseAcquired+85$2.76+$234.6177,780Direct
Oct 8, 2021Common StockPPurchaseAcquired+85$2.84+$241.4177,865Direct
Oct 11, 2021Common StockPPurchaseAcquired+85$2.73+$232.05177,950Direct
Oct 12, 2021Common StockPPurchaseAcquired+85$2.71+$230.35178,035Direct
Oct 13, 2021Common StockPPurchaseAcquired+85$2.71+$230.35178,120Direct
Oct 14, 2021Common StockPPurchaseAcquired+85$2.81+$238.85178,205Direct
Oct 15, 2021Common StockPPurchaseAcquired+85$2.76+$234.6178,290Direct
Oct 18, 2021Common StockPPurchaseAcquired+85$2.75+$233.75178,375Direct
Oct 19, 2021Common StockPPurchaseAcquired+85$2.76+$234.6178,460Direct
Oct 20, 2021Common StockPPurchaseAcquired+85$2.63+$223.55178,545Direct
Oct 21, 2021Common StockPPurchaseAcquired+85$2.65+$225.25178,630Direct
Oct 22, 2021Common StockPPurchaseAcquired+85$2.66+$226.1178,715Direct
Oct 25, 2021Common StockPPurchaseAcquired+85$2.64+$224.4178,800Direct
Oct 26, 2021Common StockPPurchaseAcquired+85$2.64+$224.4178,885Direct
Oct 27, 2021Common StockPPurchaseAcquired+85$2.61+$221.85178,970Direct
Oct 28, 2021Common StockPPurchaseAcquired+85$2.61+$221.85179,055Direct
Oct 29, 2021Common StockPPurchaseAcquired+85$2.72+$231.2179,140Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)